DIAGNOS Announces 2 screening clinics with Al Kahhal Medical Complex in the Kingdom of Saudi Arabia

Diagnos Inc.

BROSSARD, QUEBEC--(Marketwired - Aug. 22, 2017) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK)(OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the implementation of DIAGNOS CARA (Computer Assisted Retina Analysis) telemedicine platform at Al Kahhal Medical Complex clinic. With our Saudi Arabia business partner, Al Kanhoor Medical Co, we will make retinal screening exams available to the diabetic population in the cities of Dammam and AL-Hasha Eastern Province of Saudi Arabia. As per the latest International Diabetes Federation survey, Saudi Arabia ranks seventh (7) in the world with a 17.65% prevalence of diabetes in Saudi adults. This illness has almost reached the level of an epidemic in this country.